Status:
UNKNOWN
Skin Irritation Test of Ten Products
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Dermatitic Reaction of Face
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Evaluation of cutaneous tolerance of ten products by primary irritant patch test
Detailed Description
The purpose of this clinical study was the evaluation of skin irritation potential of ten products after a single application under occlusive patch on human skin.
Eligibility Criteria
Inclusion
- 20 to 70 years old, healthy male and female (sex ratio 1:1)
- No acute or chronic diseases including skin diseases.
- No current medications.
Exclusion
- Pregnancy or breast feeding.
- Abnormal blood test result/results (evaluation criteria: WBC, AST, ALT, and Creatinine)
- Back skin with moles, acne, tattoo, scars, red spots, burns, etc.
- Current dermatology medication which might affect skin condition evaluation.
- Current irritated reaction on test site.
- Participating in other clinical trial(s) within 7 days.
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05245383
Start Date
December 17 2021
End Date
June 30 2022
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan